Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant

Author(s):: Hoch, M.; Gorsel, H. van; Gerven, J. van; Dingemanse, J.

Published: 2014
Publication type: Article / Letter to editor

almorexantorexinsleep disorderspharmacokineticspharmacodynamics

Date issued: 2014-09-30
Language: English
Is part of: Journal of Clinical Pharmacology (2014), Vol. 54, no. 9, p. 979-986
hdl: 1887/104101
doi: 10.1002/jcph.297